FdaApplication

ANDA 204038

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSCIEGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2021-10-27

Products (4)

ProductActive ingredientStrengthDosage form
VALSARTANVALSARTAN40MGTABLET;ORAL
VALSARTANVALSARTAN80MGTABLET;ORAL
VALSARTANVALSARTAN160MGTABLET;ORAL
VALSARTANVALSARTAN320MGTABLET;ORAL

4 products